PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 228 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q2 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $231,420 | +20217.8% | 17,400 | -87.5% | 0.00% | -87.0% |
| Q4 2022 | $1,139 | -99.9% | 139,197 | -71.8% | 0.02% | -59.6% |
| Q2 2022 | $2,180,000 | +1315.6% | 493,119 | +747.2% | 0.06% | +1325.0% |
| Q4 2017 | $154,000 | -48.7% | 58,203 | -26.2% | 0.00% | -50.0% |
| Q4 2016 | $300,000 | +29.3% | 78,879 | +139.6% | 0.01% | +60.0% |
| Q2 2016 | $232,000 | +45.0% | 32,921 | +75.1% | 0.01% | +25.0% |
| Q1 2016 | $160,000 | -8.6% | 18,800 | -38.2% | 0.00% | -20.0% |
| Q2 2015 | $175,000 | +16.7% | 30,400 | +18.3% | 0.01% | 0.0% |
| Q1 2015 | $150,000 | – | 25,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,660,000 | $24,206,000 | 11.49% |
| Data Collective II GP, LLC | 164,249 | $1,495,000 | 5.44% |
| Decheng Capital Management III (Cayman), LLC | 1,463,872 | $13,321,000 | 4.08% |
| SB Management Ltd | 1,886,107 | $17,164,000 | 3.33% |
| Casdin Capital, LLC | 7,990,652 | $72,715,000 | 3.26% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,225,395 | $11,151,000 | 2.20% |
| Jackson Square Partners, LLC | 22,542,589 | $205,137,000 | 2.04% |
| BOURNE LENT ASSET MANAGEMENT INC | 556,865 | $5,067,000 | 1.59% |
| ARK Investment Management | 27,259,521 | $248,062,000 | 1.04% |
| Nikko Asset Management Americas, Inc. | 14,021,205 | $127,873,000 | 0.94% |